Entasis Theraputics begins Phase I study of ETX2514

Entasis Therapeutics has initiated its Phase 1 clinical study of ETX2514 to evaluate the safety, tolerability and pharmacokinetics of ETX2514 in healthy volunteers.

Source: Drug Development Technology - October 27, 2016 Category: Pharmaceuticals Source Type: news